These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 25315249)

  • 1. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
    Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
    Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
    Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
    Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of natural killer activity in hepatocellular carcinoma by treatment with antibody against granulin-epithelin precursor.
    Cheung PF; Yip CW; Ng LW; Wong CK; Cheung TT; Lo CM; Fan ST; Cheung ST
    Oncoimmunology; 2015 Jul; 4(7):e1016706. PubMed ID: 26140244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 Deficiency in Hepatocellular Carcinoma Enhances Surveillance of NK-92 through a Modulation of MICA/B.
    Lee HH; Kim D; Jung J; Kang H; Cho H
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma.
    Fang L; Gong J; Wang Y; Liu R; Li Z; Wang Z; Zhang Y; Zhang C; Song C; Yang A; Ting JP; Jin B; Chen L
    J Exp Clin Cancer Res; 2014 Sep; 33(1):76. PubMed ID: 25228093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
    Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
    Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.
    Cheung PF; Cheung TT; Yip CW; Ng LW; Fung SW; Lo CM; Fan ST; Cheung ST
    Oncotarget; 2016 Apr; 7(16):21644-57. PubMed ID: 26942873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
    Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
    Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
    Su Z; Ye X; Shang L
    Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid.
    Jinushi M; Takehara T; Tatsumi T; Kanto T; Groh V; Spies T; Kimura R; Miyagi T; Mochizuki K; Sasaki Y; Hayashi N
    Int J Cancer; 2003 Apr; 104(3):354-61. PubMed ID: 12569559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.
    Shi L; Lin H; Li G; Sun Y; Shen J; Xu J; Lin C; Yeh S; Cai X; Chang C
    Cancer Lett; 2016 Apr; 373(1):45-56. PubMed ID: 26805759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9.
    Kohga K; Takehara T; Tatsumi T; Ishida H; Miyagi T; Hosui A; Hayashi N
    Hepatology; 2010 Apr; 51(4):1264-73. PubMed ID: 20099300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.
    Jinushi M; Takehara T; Tatsumi T; Hiramatsu N; Sakamori R; Yamaguchi S; Hayashi N
    J Hepatol; 2005 Dec; 43(6):1013-20. PubMed ID: 16168521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody against granulin-epithelin precursor sensitizes hepatocellular carcinoma to chemotherapeutic agents.
    Wong NC; Cheung PF; Yip CW; Chan KF; Ng IO; Fan ST; Cheung ST
    Mol Cancer Ther; 2014 Dec; 13(12):3001-12. PubMed ID: 25253787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.
    Tsunematsu H; Tatsumi T; Kohga K; Yamamoto M; Aketa H; Miyagi T; Hosui A; Hiramatsu N; Kanto T; Hayashi N; Takehara T
    Int J Cancer; 2012 Jan; 130(2):356-64. PubMed ID: 21351090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma.
    Armeanu S; Krusch M; Baltz KM; Weiss TS; Smirnow I; Steinle A; Lauer UM; Bitzer M; Salih HR
    Clin Cancer Res; 2008 Jun; 14(11):3520-8. PubMed ID: 18519785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma.
    Kohga K; Tatsumi T; Takehara T; Tsunematsu H; Shimizu S; Yamamoto M; Sasakawa A; Miyagi T; Hayashi N
    J Hepatol; 2010 Jun; 52(6):872-9. PubMed ID: 20395004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.
    Okita R; Mougiakakos D; Ando T; Mao Y; Sarhan D; Wennerberg E; Seliger B; Lundqvist A; Mimura K; Kiessling R
    J Immunol; 2012 Mar; 188(5):2136-45. PubMed ID: 22301547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulin-epithelin precursor interacts with 78-kDa glucose-regulated protein in hepatocellular carcinoma.
    Yip CW; Lam CY; Poon TCW; Cheung TT; Cheung PFY; Fung SW; Wang XQ; Leung ICY; Ng LWC; Lo CM; Tsao GSW; Cheung ST
    BMC Cancer; 2017 Jun; 17(1):409. PubMed ID: 28601093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells.
    Cheung PF; Cheng CK; Wong NC; Ho JC; Yip CW; Lui VC; Cheung AN; Fan ST; Cheung ST
    PLoS One; 2011; 6(12):e28246. PubMed ID: 22194816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.